INS and obesity disorder: Here, we describe a number of important intestinal immune cell-mediated mechanisms that facilitate the development of obesity-associated metabolic tissue inflammation, insulin resistance, intestinal hormone bioavailability, and glucose dysregulation (Fig. 2).